PL-3994 | m-entrepreneurship.com

Product Name :
PL-3994

Search keywords :
PL-3994

drugId :
null

Target Vo:
Natriuretic peptide receptor 1

Target Vo Short Name :
NPR1

Moa_Name:
Natriuretic peptide receptor 1 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Palatin Technologies Inc

Active Company_Name :
Palatin Technologies Inc

Active Indication_Name:
Heart Failure

In Active Indication_Name:
Hypertension

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Fos Antibody (YA506)
PKC alpha Antibody
SMYD4 Antibody (YA671): SMYD4 Antibody (YA671) is a non-conjugated and Mouse origined monoclonal antibody about 89 kDa, targeting to SMYD4 (7C8). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts